Filing Details

Accession Number:
0001209191-23-055879
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-17 18:20:30
Reporting Period:
2023-11-15
Accepted Time:
2023-11-17 18:20:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1845337 Day One Biopharmaceuticals Inc. DAWN Pharmaceutical Preparations (2834) 832415215
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1863107 Jeremy Bender 2000 Sierra Point Parkway, Suite 501
Brisbane CA 94005
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-11-15 3,562 $0.00 707,786 No 4 M Direct
Common Stock Acquisiton 2023-11-15 4,750 $0.00 712,536 No 4 M Direct
Common Stock Disposition 2023-11-16 3,107 $11.69 709,429 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2023-11-15 3,562 $0.00 3,562 $0.00
Common Stock Restricted Stock Units Disposition 2023-11-15 4,750 $0.00 4,750 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
28,504 No 4 M Direct
57,000 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 221,837 Indirect See Footnote
Common Stock 300,025 Indirect See Footnote
Common Stock 251,636 Indirect See Footnote
Common Stock 270,226 Indirect See Footnote
Footnotes
  1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration.
  2. The sale of shares is for the sole purpose of covering the Reporting Person's tax liability with respect to the settlement of RSUs.
  3. Represents shares held by The Jeremy Bender 2022 Grantor Retained Annuity Trust under Irrevocable Trust Agreement dated March 29, 2022 of which the Reporting Person is trustee.
  4. Represents shares held by The Jeremy Bender 2023 Grantor Retained Annuity Trust dated June 27, 2023.
  5. Represents shares held by The Melissa Bender 2022 Grantor Retained Annuity Trust under Irrevocable Trust Agreement dated March 29, 2022 of which the Reporting Person's spouse is trustee.
  6. Represents shares held by The Melissa Bender 2023 Grantor Retained Annuity Trust, dated June 27, 2023.
  7. The RSUs vest as to 1/16th of the total award in quarterly installments on February 15, May 15, August 15 and November 15, subject to the Reporting Person's provision of service to the Issuer on each vesting date.